Tag : treating

Latest News

Study suggests novel approach to treating adults with autism spectrum disorder

Newsemia
A team of scientists at Florida Atlantic University has uncovered a brain-signaling pathway that can be pharmacologically manipulated in genetically engineered mice to reverse an...
Pediatrics

Guided by CRISPR, Prenatal Gene Editing Shows Proof-of-Concept in Treating Congenital Disease before Birth

Newsemia
For the first time, scientists have performed prenatal gene editing to prevent a lethal metabolic disorder in laboratory animals, offering the potential to treat human...
Latest News

Leadiant Biosciences announces FDA approval of Revcovi for treating pediatric, adult ADA-SCID patients

Newsemia
Leadiant Biosciences, Inc. today announced that the Food and Drug Administration has granted approval to Revcovi (elapegademase-lvlr) injection in the U.S. Revcovi is a new...
Dentistry

Ibuprofen, acetaminophen more effective than opioids in treating dental pain

Newsemia
Ibuprofen and other nonsteroidal anti-inflammatory drugs (NSAIDs) alone or in combination with acetaminophen are better at easing dental pain than opioids, according to new research....
Latest News

Alnylam announces positive results from Phase 1/2 study of lumasiran for treating primary hyperoxaluria-1

Newsemia
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today updated positive results from its Phase 1/2 clinical study of lumasiran, an investigational, subcutaneously administered...
Latest News

CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL

Newsemia
AbbVie, a research-based global biopharmaceutical company, announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has granted a...
Neurology

Alector announces initiation of Phase 1 trial of AL001 for treating frontotemporal dementia

Newsemia
Alector, a privately held biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration, today announced the initiation of its Phase 1...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy